Delivery Order SPE2DR25D2104-SPE2DR26F3TDQ
- Not listed
- On January 7, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,265.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 8, 2026 and performance to be executed in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. and serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $4,586.80. The contract represents a firm fixed price delivery order with a completion date of December 19, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the vendor's established...
- The Defense Logistics Agency awarded a delivery order valued at $4,566.18 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on January 5, 2026, with a completion date of January 6, 2026. This is a firm fixed-price delivery order issued without a set-aside designation, competitively awarded under an existing contract vehicle. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $2,026.98. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The contract is scheduled for completion by October 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $2,616.66 with a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of December 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's critical role as a pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors at a firm fixed price ceiling of $2,907.40. This non-set-aside delivery order, with an ultimate completion date of November 14, 2025, represents a continuation of pharmaceutical supply support under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $7,780.03 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen injectors on November 26, 2025, with completion expected by November 28, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the broader federal medical procurement framework supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $3,164.60. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The contract is scheduled for completion by January 6, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,747.04 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml) on December 19, 2025, with an ultimate completion date of December 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $1,628.68 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections with an ultimate completion date of August 19, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to a qualified vendor. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3TDQDelivery Order
On January 8, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,189.43 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors with 0.5 mL dosage units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 9, 2026, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made on a full and open competitive basis with no set-aside designation. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. AmerisourceBergen's contract awards with DLA demonstrate its capability to efficiently fulfill government requirements for essential pharmaceutical commodities needed by military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/7/26 |